Author

A. Linderholm

University of California, DavisORCID 0000-0002-8561-3089Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

A. Linderholm3 papers

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Organism:human· 1

Frequent Co-Authors

Imre NothiD· 2 shared Justin M. OldhamiD· 2 shared Naftali KaminskiiD· 2 shared Adrián Muñoz‐BarreraiD· 1 shared Amy Stockwell· 1 shared Andrew Gordon NicholsoniD· 1 shared Ayodeji AdegunsoyeiD· 1 shared Beatriz Guillén‐GuíoiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Imre NothORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD103+ Dendritic Cell - Fibroblast Crosstalk via TLR9 and AHR Signaling Drives Lung Fibrogenesis

Hannah M. Carter, Rita Medina Costa, Taylor Sterling Adams, Talon M. Gilchrist, Claire E. Emch, Monica Bame, Justin M. Oldham, Steven Kenneth Huang, A. Linderholm, Imre Noth, Naftali Kaminski, Bethany B. Moore, Stephen J. Gurczynski

This study identifies CD103+ dendritic cell-fibroblast crosstalk via TLR9 and AHR signaling as a driver of lung fibrosis in IPF, showing that inhibiting AHR signaling reduces fibrosis.

JCI Insight · Feb 18, 2025Peer-reviewedImmunology

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis

Justin M. Oldham, Richard J. Allen, Jose Miguel Lorenzo-Salazar, Philip L. Molyneaux, Shwu‐Fan Ma, Chitra Joseph, John S. Kim, Beatriz Guillén‐Guío, Tamara Hernández-Beeftink, Jonathan A. Kropski, Yong Huang, Cathryn T. Lee, Ayodeji Adegunsoye, Janelle Vu Pugashetti, A. Linderholm, , Imre Noth

The paper identifies four novel genetic variants associated with IPF survival, including a PCSK6 variant, and suggests PCSK6 as a prognostic biomarker and therapeutic target.

American Journal of Respiratory and Critical Care Medicine · Feb 13, 2023Peer-reviewedGenetic & Genomic Medicine